Tracking antibiotic resistance in pneumonia patients
Part of Infections, Lungs & breathing clinical trials.
This study uses advanced genetic testing to monitor antibiotic-resistant bacteria in people with pneumonia. It aims to understand how resistance develops and improve treatment choices.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with severe or mild pneumonia based on standard guidelines.
- You are an adult or child meeting the specific pneumonia severity criteria.
- You have a leftover sample from a standard test, like a nose swab, throat swab, sputum, blood, or lung fluid.
- Your sample is not contaminated, and if you had lung fluid drawn, there was enough (at least 200 microliters).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people with HIV/AIDS who develop severe pneumonia or septic shock. It uses a special genetic test (metagenomic next-generation sequencing) to find the exact germ causing the infection so doctors can choose the right antibiotic.
This is a retrospective study (looking back at past patient records) of people hospitalized with pneumonia to understand how the disease progresses and what factors affect recovery. Researchers will examine medical records of pneumonia patients admitted within 72 hours of symptom onset to identify patterns in who recovers well and who develops serious complications.
This study uses a powerful genetic test (next-generation sequencing) to find the cause of respiratory infections when standard tests fail. It may help identify hard-to-detect viruses, bacteria, or fungi in your lung or airway samples.
This study looks at how bacteria in your body (microbiome) affect how sick you get from severe pneumonia. It may help doctors find better ways to treat people with serious lung infections who need breathing support.
This study tests a method called tNGS that looks for germs in your lung fluid. It aims to find why your pneumonia is not getting better, so doctors can choose the right treatment.
This trial looks at whether a special genetic test (tNGS) can predict which antibiotics will work for bacteria causing lung infections. It may help doctors choose the right treatment faster.
Hear when a new Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.